Establishment Labs gains as first patients receive Motiva implants

spawns Shares of Establishment Labs ( NASDAQ: ESTA ) bounced back on Wednesday after the MedTech announced that the first group of patients in the U.S. has successfully undergone surgeries to receive its recently approved Motiva breast implants.

Last week, Establishment Labs ( ESTA.